SMS PHARMACEUTICALS
Quarterly Results Analysis [Dec2023]
SMS PHARMACEUTICALS Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹161 Cr | ₹167 Cr | ₹135 Cr | ₹149 Cr | ₹149 Cr | ₹159 Cr | ₹64 Cr | ₹61 Cr |
Expenses | ₹132 Cr | ₹139 Cr | ₹109 Cr | ₹126 Cr | ₹130 Cr | ₹146 Cr | ₹65 Cr | ₹65 Cr |
Operating Income | ₹29 Cr | ₹28 Cr | ₹26 Cr | ₹23 Cr | ₹19 Cr | ₹14 Cr | ₹-1 Cr | ₹-4 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr |
Depreciation | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
Profit Before Tax | ₹17 Cr | ₹15 Cr | ₹13 Cr | ₹11 Cr | ₹7 Cr | ₹1 Cr | ₹-13 Cr | ₹-16 Cr |
Profit After Tax | ₹12 Cr | ₹12 Cr | ₹9 Cr | ₹8 Cr | ₹5 Cr | ₹1 Cr | ₹-10 Cr | ₹9 Cr |
EPS | ₹1.36 | ₹1.39 | ₹1.10 | ₹0.73 | ₹0.44 | ₹-0.24 | ₹-1.51 | ₹0.73 |
Industry Peers & Returns | 1W | 1M | 1Y |
SMS PHARMACEUTICALS | 3.4% | 30.5% | 181.2% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
SMS PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -3.10 % |
Y-o-Y | 8.52 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹161 Cr | -3.10 | |
Sep2023 | ₹167 Cr | 23.13 | |
Jun2023 | ₹135 Cr | -9.43 | |
Mar2023 | ₹149 Cr | 0.42 | |
Dec2022 | ₹149 Cr | -6.67 | |
Sep2022 | ₹159 Cr | 147.61 | |
Jun2022 | ₹64 Cr | 5.70 | |
Mar2022 | ₹61 Cr | - |
SMS PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 4.23 % |
Y-o-Y | 56.64 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹29 Cr | 4.23 | |
Sep2023 | ₹28 Cr | 6.25 | |
Jun2023 | ₹26 Cr | 12.67 | |
Mar2023 | ₹23 Cr | 25.53 | |
Dec2022 | ₹19 Cr | 36.50 | |
Sep2022 | ₹14 Cr | Positive | |
Jun2022 | ₹-1 Cr | Negative | |
Mar2022 | ₹-4 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 7.61 % |
Y-o-Y | 44.37 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 17.96% | 7.61 | |
Sep2023 | 16.69% | -13.75 | |
Jun2023 | 19.35% | 24.44 | |
Mar2023 | 15.55% | 25.00 | |
Dec2022 | 12.44% | 46.18 | |
Sep2022 | 8.51% | Positive | |
Jun2022 | -1.26% | Negative | |
Mar2022 | -7.29% | - |
SMS PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 2.03 % |
Y-o-Y | 132.96 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹12 Cr | 2.03 | |
Sep2023 | ₹12 Cr | 36.75 | |
Jun2023 | ₹9 Cr | 9.20 | |
Mar2023 | ₹8 Cr | 52.90 | |
Dec2022 | ₹5 Cr | 620.77 | |
Sep2022 | ₹1 Cr | Positive | |
Jun2022 | ₹-10 Cr | Negative | |
Mar2022 | ₹9 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 5.26 % |
Y-o-Y | 114.37 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 7.61 % | 5.26 | |
Sep2023 | 7.23 % | 11.06 | |
Jun2023 | 6.51 % | 20.56 | |
Mar2023 | 5.4 % | 52.11 | |
Dec2022 | 3.55 % | 671.74 | |
Sep2022 | 0.46 % | Positive | |
Jun2022 | -15.83 % | Negative | |
Mar2022 | 14.61 % | - |
SMS PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -2.16 % |
Y-o-Y | 209.09 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹1.36 | -2.16 | |
Sep2023 | ₹1.39 | 26.36 | |
Jun2023 | ₹1.1 | 50.68 | |
Mar2023 | ₹0.73 | 65.91 | |
Dec2022 | ₹0.44 | Positive | |
Sep2022 | ₹-0.24 | Negative | |
Jun2022 | ₹-1.51 | Negative | |
Mar2022 | ₹0.73 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD